Low-dose aspirin is associated with an increased risk of haemorrhage; but not in people with diabetes who have a high baseline rate of bleeding

Evid Based Nurs. 2013 Apr;16(2):55-6. doi: 10.1136/eb-2012-100951. Epub 2012 Nov 9.

Abstract

Implications for practice and research: Low-dose aspirin (≤ 300 mg/day) increases the risk of major bleeding. Individuals with diabetes have a higher risk of bleeding independent of aspirin exposure. Future work should include comparative effectiveness studies to help inform treatment strategies based on individual risks, benefits, patient preferences and values.

Publication types

  • Comment